Blade Air MobilityBLDE
BLDE
About: Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
Employees: 322
0
Funds holding %
of 7,433 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
64% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 28
53% more capital invested
Capital invested by funds: $117M [Q1] → $179M (+$62M) [Q2]
35% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 20
3% more funds holding
Funds holding: 117 [Q1] → 121 (+4) [Q2]
1.41% more ownership
Funds ownership: 53.32% [Q1] → 54.73% (+1.41%) [Q2]
78% less call options, than puts
Call options by funds: $638K | Put options by funds: $2.88M
Research analyst outlook
We haven’t received any recent analyst ratings for BLDE.
Financial journalist opinion
Based on 11 articles about BLDE published over the past 30 days
Neutral
GlobeNewsWire
2 weeks ago
Blade Air Mobility to Present at the Oppenheimer 28th Annual Technology, Internet & Communications Conference
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), a technology-powered air mobility platform, today announced that Will Heyburn, Chief Financial Officer, will present at the Oppenheimer 28th Annual Technology, Internet & Communications Conference on Monday, August 11, 2025 at 2:55pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.blade.com/news-events.
Negative
MarketBeat
2 weeks ago
Joby Deal Gives Blade New Direction, But Stock Lacks Lift
It's been quite the week for Blade Air Mobility Inc. NASDAQ: BLDE. On August 4, Blade and Joby Aviation Inc. NYSE: JOBY announced the sale of Blade's passenger mobility business to Joby for up to $125 million.
Positive
The Motley Fool
2 weeks ago
Blade (BLDE) Q2 Revenue Jumps 10%
Blade (BLDE) Q2 Revenue Jumps 10%
Neutral
Seeking Alpha
3 weeks ago
Blade Air Mobility: Disappointing Exit
Blade Air Mobility sold its passenger/UAM division to Joby Aviation, shifting focus to medical organ transport and rebranding as Strata Critical Medical. The deal improves Blade's capital position but sacrifices the higher-growth air taxi opportunity, disappointing original investment expectations. Strata now controls 30% of the organ logistics market, with strong growth, solid profitability, and trades at an attractive valuation below 1x sales.
Neutral
Seeking Alpha
3 weeks ago
Blade Air Mobility, Inc. (BLDE) Q2 2025 Earnings Call Transcript
Blade Air Mobility, Inc. (NASDAQ:BLDE ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Mathew Schneider - Vice President of Investor Relations & Strategic Finance Melissa M. Tomkiel - President, General Counsel & Corporate Secretary Robert S.
Negative
Zacks Investment Research
3 weeks ago
Blade Air Mobility, Inc. (BLDE) Reports Q2 Loss, Tops Revenue Estimates
Blade Air Mobility, Inc. (BLDE) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.06 per share a year ago.
Neutral
GlobeNewsWire
3 weeks ago
Blade Air Mobility Announces Second Quarter 2025 Results
Medical revenue increased 17.6% year-over-year in Q2 2025 Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the prior year to $3.2 million in Q2 2025 (1) Blade Passenger division to be sold to Joby Aviation for up to $125 million; Blade's Medical division will remain a standalone public company, rebrand as Strata Critical Medical ("Strata") Sale is expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade" or the "Company"), today announced financial results for the second quarter ended June 30, 2025. GAAP FINANCIAL RESULTS (in thousands except percentages, unaudited) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change Revenue $ 70,801 $ 67,945 4.2 % $ 125,107 $ 119,459 4.7 % Cost of revenue $ 53,064 $ 51,591 2.9 % $ 95,392 $ 92,966 2.6 % Software development 915 971 (5.8 ) % 1,727 1,641 5.2 % General and administrative 20,142 25,136 (19.9 ) % 37,456 42,345 (11.5 ) % Selling and marketing 1,634 2,396 (31.8 ) % 3,069 4,524 (32.2 ) % Total operating expenses $ 75,755 $ 80,094 (5.4 ) % $ 137,644 $ 141,476 (2.7 ) % Loss from operations $ (4,954 ) $ (12,149 ) (59.2 ) % $ (12,537 ) $ (22,017 ) (43.1 ) % Net loss $ (3,743 ) $ (11,326 ) (67.0 ) % $ (7,236 ) $ (15,560 ) (53.5 ) % Gross profit $ 12,889 $ 11,336 13.7 % $ 20,982 $ 17,188 22.1 % Gross margin 18.2 % 16.7 % 150bps 16.8 % 14.4 % 240bps NON-GAAP (1) FINANCIAL RESULTS (in thousands except percentages, unaudited) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change Revenue $ 70,801 $ 67,945 4.2 % $ 125,107 $ 119,459 4.7 % Cost of revenue 53,064 51,591 2.9 % 95,392 92,966 2.6 % Flight Profit 17,737 16,354 8.5 % 29,715 26,493 12.2 % Flight Margin 25.1 % 24.1 % 100bps 23.8 % 22.2 % 160bps Adjusted SG&A 15,399 15,834 (2.7 )% 29,370 29,602 (0.8 )% Depreciation included in cost of revenue 852 438 NM(2) 1,607 521 NM(2) Adjusted EBITDA $ 3,190 $ 958 233.0 % $ 1,952 $ (2,588 ) NM(2) Adjusted EBITDA as a percentage of Revenue 4.5 % 1.4 % 310bps 1.6 % (2.2 )% NM(2) Passenger Adjusted EBITDA $ 2,389 $ 782 205.5 % $ 2,443 $ (1,869 ) NM(2) Medical Adjusted EBITDA $ 6,039 $ 5,524 9.3 % $ 10,137 $ 9,933 2.1 % Adjusted unallocated corporate expenses and software development $ (5,238 ) $ (5,348 ) (2.1 )% $ (10,628 ) $ (10,652 ) (0.2 )% (1) See "Use of Non-GAAP Financial Information" and "Key Metrics and Non-GAAP Financial Information" sections attached to this release for an explanation of Non-GAAP measures used and reconciliations to the most directly comparable GAAP financial measure.
Positive
Schaeffers Research
3 weeks ago
Joby Stock Takes Flight After Deal With Blade Air Mobility
Shares of Joby Aviation Inc (NYSE:JOBY) soared this morning after the company announced its acquisition of fellow aviation name Blade Air Mobility's (BLDE) helicopter ride-share business for $125 million.
Positive
Seeking Alpha
3 weeks ago
Joby Aviation: Why Acquiring Blade Air Mobility Makes Sense
Joby Aviation is attractive among eVTOL stocks due to strong certification progress and a clear path to commercial service entry. Acquiring Blade Air Mobility would give Joby instant access to booking platforms, operating certificates, and crucial infrastructure for air taxi rollout. Blade's partnerships and exclusive terminal access would accelerate Joby's eVTOL deployment, reducing the need for heavy infrastructure investments.
Positive
TechCrunch
3 weeks ago
Joby Aviation to buy Blade Air Mobility's ride-share business
Electric air taxi developer Joby Aviation has agreed to buy Blade Air Mobility's helicopter ride-share business for as much as $125 million.
Charts implemented using Lightweight Charts™